Abstract
While our data do not show a significant difference in response to cytotoxic chemotherapy between ER-positive and ER-negative patients, they clearly do not confirm the results of Lippman and co-workers, and there is a trend for our data to support those of Kiang and associates. We believe that it is unlikely that estrogen receptor assays will prove to have important predictive value for response to cytotoxic chemotherapy. However, more prospective studies published in detail with a larger number of patients will be needed to resolve this issue.
| Original language | English |
|---|---|
| Title of host publication | Breast. Diseases of the Breast |
| Pages | 26-31 |
| Number of pages | 6 |
| Volume | 7 |
| Edition | 2 |
| State | Published - Dec 1 1981 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Correlation between estrogen receptors and response to nonhormonal chemotherapy in metastatic breast cancer. / Umsawasdi, T.; Vogel, Charles; Voigt, W.
Breast. Diseases of the Breast. Vol. 7 2. ed. 1981. p. 26-31.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Correlation between estrogen receptors and response to nonhormonal chemotherapy in metastatic breast cancer
AU - Umsawasdi, T.
AU - Vogel, Charles
AU - Voigt, W.
PY - 1981/12/1
Y1 - 1981/12/1
N2 - While our data do not show a significant difference in response to cytotoxic chemotherapy between ER-positive and ER-negative patients, they clearly do not confirm the results of Lippman and co-workers, and there is a trend for our data to support those of Kiang and associates. We believe that it is unlikely that estrogen receptor assays will prove to have important predictive value for response to cytotoxic chemotherapy. However, more prospective studies published in detail with a larger number of patients will be needed to resolve this issue.
AB - While our data do not show a significant difference in response to cytotoxic chemotherapy between ER-positive and ER-negative patients, they clearly do not confirm the results of Lippman and co-workers, and there is a trend for our data to support those of Kiang and associates. We believe that it is unlikely that estrogen receptor assays will prove to have important predictive value for response to cytotoxic chemotherapy. However, more prospective studies published in detail with a larger number of patients will be needed to resolve this issue.
UR - http://www.scopus.com/inward/record.url?scp=0019795448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019795448&partnerID=8YFLogxK
M3 - Chapter
VL - 7
SP - 26
EP - 31
BT - Breast. Diseases of the Breast
ER -